Literature DB >> 32865520

p38 MAPK reins in right ventricular growth.

Tongbin Wu, Ju Chen.   

Abstract

The right ventricle (RV) is involved in systemic circulation in the fetal mammalian heart but quickly transitions to being solely responsible for pulmonary circulation after birth when the left ventricle (LV) becomes the systemic ventricle. To handle the increased workload, LV growth greatly outpaces that of the RV during postnatal stages. However, the molecular basis for this differential growth pattern between the 2 chambers is largely unknown. In this issue of the JCI, Yokota et al. reveal that the p38 mitogen-activated protein kinase (MAPK)/IRE1α/XBP1 axis specifically controls postnatal RV growth by suppressing cell cycle regulatory genes.

Entities:  

Year:  2020        PMID: 32865520      PMCID: PMC7524502          DOI: 10.1172/JCI140793

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Isolated noncompaction of right ventricle--a case report.

Authors:  Arun Ranganathan; Gnanavelu Ganesan; Venkatesan Sangareddi; Arunachalam Piramanayagam Pillai; Alagesan Ramasamy
Journal:  Echocardiography       Date:  2012-03-09       Impact factor: 1.724

Review 2.  How to make a heart: the origin and regulation of cardiac progenitor cells.

Authors:  Stéphane D Vincent; Margaret E Buckingham
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 3.  Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure.

Authors:  M M Winter; B J Bouma; M Groenink; T C Konings; J G P Tijssen; D J van Veldhuisen; B J M Mulder
Journal:  Heart       Date:  2008-11-25       Impact factor: 5.994

Review 4.  Congenital cardiovascular malformations and the fetal circulation.

Authors:  A M Rudolph
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2009-03-25       Impact factor: 5.747

5.  Magnetic resonance assessment of prevalence and correlates of right ventricular abnormalities in isolated left ventricular noncompaction.

Authors:  Gaetano Nucifora; Giovanni D Aquaro; Pier Giorgio Masci; Alessandro Pingitore; Massimo Lombardi
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

Review 6.  Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Domenico Corrado; Mark S Link; Hugh Calkins
Journal:  N Engl J Med       Date:  2017-01-05       Impact factor: 91.245

Review 7.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

8.  XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

Authors:  H Yoshida; T Matsui; A Yamamoto; T Okada; K Mori
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

Review 9.  Signaling and transcriptional networks in heart development and regeneration.

Authors:  Benoit G Bruneau
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

10.  IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.

Authors:  Xia Sheng; Hatice Zeynep Nenseth; Su Qu; Omer F Kuzu; Turid Frahnow; Lukas Simon; Stephanie Greene; Qingping Zeng; Ladan Fazli; Paul S Rennie; Ian G Mills; Håvard Danielsen; Fabian Theis; John B Patterson; Yang Jin; Fahri Saatcioglu
Journal:  Nat Commun       Date:  2019-01-24       Impact factor: 14.919

View more
  1 in total

1.  18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells.

Authors:  Ying-Hua Luo; Cheng Wang; Wan-Ting Xu; Yu Zhang; Tong Zhang; Hui Xue; Yan-Nan Li; Zhong-Ren Fu; Ying Wang; Cheng-Hao Jin
Journal:  Onco Targets Ther       Date:  2021-10-22       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.